HS-20094
RISE-1
Regeneron · Phase 3 · Not yet recruiting · Enrollment 3000
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Olatorepatide-Dose 1 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide-Dose 2 | n/r | n/r | n/r | n/r | n/r |
| Olatorepatide-Dose 3 | n/r | n/r | n/r | n/r | n/r |
| Placebo-Dose 1 | n/r | n/r | n/r | n/r | n/r |
| Placebo-Dose 2 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.